Compare RIV & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIV | NREF |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Real Estate Investment Trusts |
| Sector | Finance | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.6M | 296.5M |
| IPO Year | 2010 | N/A |
| Metric | RIV | NREF |
|---|---|---|
| Price | $10.06 | $15.12 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $16.25 |
| AVG Volume (30 Days) | ★ 91.4K | 65.2K |
| Earning Date | 01-01-0001 | 11-05-2026 |
| Dividend Yield | 12.85% | ★ 13.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.99 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.12 | $12.36 |
| 52 Week High | $12.15 | $18.43 |
| Indicator | RIV | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 31.24 | 35.06 |
| Support Level | N/A | $14.45 |
| Resistance Level | $10.64 | $16.10 |
| Average True Range (ATR) | 0.15 | 0.45 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 9.75 | 18.55 |
Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.